I agree and as I said before J and J should use their increasing fame as highly visible patients to find sponsors to their rehab. Just imagine Jordan or Jessi or both on TV endorsing the NEMS suit.
The owner is nuts if he does not see the benefits of such an advertisement. J and J are first and they will be part of medical history.
Thank you fact man, the perfect scenario for the reverse and start trading on NASDAQ within a few weeks.
alex, I agree, smart money knows that this will be a successful reverse without a haircut and the listing on NASDAQ will be an instant booster. I expect 15 Dollars days after the up listing or even before. The company is lowballing their expectations around 10 dollars.
I don't know how you time a severe accident , right patient, right hospital…………anything can happen, but I for sure do not count on such a perfect enrollment.
"We evaluated previously executed reverse splits associated with an uplisting and found that 1-for-4 reverse splits priced in the $10 range generally performed well post-split."
I agree, we will perform well. A transparent well executed reverse in a stock with upward trajectory is normally not the target of short interest . Shorts prey on companies which have obvious trouble.
NO TROUBLE HERE
I loaded up CTSO , after a reverse and the intend to up list was announced . 300 % gain so far.
I cannot imagine that NVIV would do this reverse right now without substantial good news coming soon.
If NVIV follows the success of CTSO , we are looking at a share price of 36 Dollars in a few months.
when I pointed out the marketing/advertising value of J and J.
I bet the manufacturer of rehabilitation gear J and J are using ( bike ….) would be interested to have them as spokespeople.
So here would be my deal with them. You contribute to my rehab cost and after my recovery I will be available for advertising of your product. J and J are for me way more valuable and interesting for health advertisement than those who lose some pounds, get rid of pimples or get a six pack.
As far as I know there were certain shortcomings with the study which is more than common in Biotech. The FDA obviously looked into it and allowed the human trial in a revised protocol.
The important part is, that as the human trials are evolving the science facts are now being followed by the most stringent parameters . This is the emphasis in my DD. If you try to dwell on any possible flaw in an animal study , go ahead but do not expect help from those who have moved on to more important DD
mike, my Grandma also taught me lots of ethical value stuff, but she did not teach me stock investing unless I consider " the early bird gets the worm" a hidden investment advice. When everything is confirmed, the real fat worm is already gone.
Thanks for your sound investment approach, but that part I cover with diversification :-) :-) :-)
Many investors in Biotech companies like to see the company "going alone" to achieve maximum final gain.
The problem I have observed over many years is that without large robust trials, statistical significance is often not getting achieved. Shortcuts in trial size often lead to failures . This is why I prefer a large partner , even if it means getting less of the potential gain.
If SYN finds a "LARGE" PARTNER for MS III, I think the SP will fly and provide solid financing for the I/II trials via a secondary offering.
This pair has tremendous marketing potential . A charming girl and a tough young guy getting back their live with the help of the scaffold.
Think advertising , and you will get the picture.
Compare the SCAFFOLD to the invention of the LADDER . I am sure everybody would like to have a patent on the ladder. :-) :-) :-) $$$$$$$
They normally are a fact of most Message Boards and appeals not to respond to them normally don't work.
But we have quite a large number of positive investors on this MB who also want to support J and J because they are just very fine young folks who many just like for what they are.
Please DO NOT respond to the basher/creeps. A bunch of red thumps and No Response says enough what we think of them.
Please do not give them what they want : Engagement
On this MB , I think it can work.